Actueel onderzoek

Momenteel worden de onderstaande trials uitgevoerd:

The TURN trial, Transplantation of faeces in Ulcerative colitis; Restoring Nature's homeostasis.

Deelnemende centra : AMC
Ziekte : Ulcerative Colitis
Product/interventie : Feces
Meer informatie : Nederlands Trial Register: NTR2862

A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)

Deelnemende centra : AMC, VUmc, Erasmus MC
Bedrijf : Bristol-Myers Squibb
Ziekte : Ulcerative Colitis
Product/interventie : Anti-ip10 antilichaam
Meer informatie : Clinical Trials: NCT01294410

Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients

Deelnemende centra : AMC, MUMC, VUmc, Erasmus MC
Bedrijf : Pfizer
Ziekte : Ulcerative Colitis
Product/interventie : Anrukinzumab iv (anti-IL13)
Meer informatie : Clinical Trials: NCT01284062

Dilstent 2 ballon vs stent bij dominante strictuur

Deelnemende centra : Erasmus, AMC
Bedrijf : AMC
Ziekte : Primary Sclerosing Cholangitis
Product/interventie : Ballon vs stent

Cost of Inflammatory Bowel Disease in the Netherlands

Bedrijf : Coin
Ziekte : Ulcerative Colitis & Crohn's Disease
Product/interventie : Vragenlijst
Meer informatie : Op

Expecting the best: limiting drug transport in pregnant inflammatory bowel disease patients

Deelnemende centra : Erasmus MC
Bedrijf : Erasmus
Ziekte : Ulcerative Colitis & Crohn's Disease
Product/interventie : Pregnancy

Laparoscopic ileocolic resection versus infliximab treatment of recurrent distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).

Bedrijf : Gut Club
Ziekte : Crohn's Disease
Product/interventie : Ileocoecaal resectie
Meer informatie : Op en Nederlands Trial Register: NTR1150

A Two Part, Multi-Centre, Randomized, Placebo-Controlled, Double-Blind Study of TRK-170 for the Treatment of Crohn’s Disease

Deelnemende centra : UMCU
Bedrijf : Toray
Ziekte : Crohn's Disease
Product/interventie : Oraal TRK-170
Meer informatie : Clinical Trials: NCT01345799

Efficacy and Safety of Two Treatment Models in Subjects With Moderate to Severe Crohn's Disease (CALM)

Deelnemende centra : LUMC, AMC
Bedrijf : Abbott
Ziekte : Crohn's Disease
Product/interventie : Adalimumab
Meer informatie : Clinical Trials: NCT01235689

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence (PREVENT)

Deelnemende centra : LUMC, Erasmus MC, MUMC, VUmc
Bedrijf : Centocor
Ziekte : Crohn's Disease
Product/interventie : Infliximab
Meer informatie : Clinical Trials: NCT01190839

A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease (SHIELD-1)

Deelnemende centra : AMC, Erasmus MC
Bedrijf : GlaxoSmithKline
Ziekte : Crohn's Disease
Product/interventie : GSK1605786A (CCR9 antagonist)
Meer informatie : Clinical Trials: NCT01277666

Endoscopic Balloon Dilatation of narrowed intestinal connection in Crohn's disease with or without extra local medication

Deelnemende centra : UMCU
Bedrijf : UMCU
Ziekte : Crohn's Disease
Product/interventie : Triamcinolone en budenofalk
Meer informatie : Nederlands Trial Register: NTR1378

Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients with Refractory Perianal Crohn's Disease

Deelnemende centra : LUMC
Bedrijf : LUMC
Ziekte : Crohn's Disease
Product/interventie : MSC and fistulas
Meer informatie : Clinical Trials: NCT01144962

A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

Deelnemende centra : VU, AMC, MUMC, Erasmus MC
Bedrijf : Centocor
Ziekte : Crohn's Disease
Product/interventie : Ustekinumab
Meer informatie : Clinical Trials: NCT01369355